“…The contrasted results observed for these two compounds (Table I) suggest that this difference lies in the cell's metabolic capability. While CPA's genotoxicity for HepG2 cells has previously been reported [Westerink et al, 2011;Tsamou et al, 2012], the genotoxic potential of DMNA for these cells without the addition of a bioactivation system has not been demonstrated [Westerink et al, 2007b;Tsamou et al, 2012], probably due to poor CYP2E1 expression in this cell line [Caro et al, 2009]. Our results for the five other compounds (BaP, DMBA, AFB1, 2-AAF, and DAT), which share a genotoxic MOA related to a specific biotransformation process, confirmed that HepG2 cells express functional CYP1A1, 1A2, 1B1, and 3A4 activities.…”